1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes

Journal of Dermatological Science

Volumn 15, Issue 3, 1997, Pages 207-213

  Koizumi, Hiroko ^a   Kaplan, Alex ^a,b   Shimizu, Tadamichi ^a   Ohkawara, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

1,25 Dihydroxyvitamin D3; 22 Oxacalcitriol; Interleukin 8; OCT; Psoriasis

Indexed keywords

22 OXACALCITRIOL; ALFACALCIDOL; CALCITRIOL; GAMMA INTERFERON; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS;

CALCITRIOL; CELL DIVISION; CELL LINE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-8; KERATINOCYTES; MALE; REFERENCE VALUES;

EID: 0030817616     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(97)00609-9     Document Type: Article

References (36)

1. Barker JNWN, Jones ML, Mitra RS, Crockett-Torabe E, Fantone JC, Kunkel SL, Warren JS, Vishva MD, Nickoloff BJ: Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139: 869-876, 1991.
2. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med 167: 1364-1376, 1988.
3. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil activating protein (NAP1) is also chemotactic for T lymphocytes. Science 243: 1464-1466, 1989.
4. Michel G, Kemeny L, Peter RU, Beetz A, Ried C, Arenberger P, Ruzicka T: Interleukin-8 receptor-mediated chcmotaxis of normal human epidermal cells. FEBS Lett 305: 241-243, 1992.
5. Tuschil A, Lam C, Haslberger A, Lindley I: Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99: 294-298, 1992.
6. Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 97: 73-79, 1991.
7. Nickoloff BJ, Karabin GD, Barker JNWN, Griffiths CEM, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138: 129-140, 1991.
8. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144: 820-828, 1994.
9. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 68: 31-36, 1989.
10. Barker JNWN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor-α and interferon-γ in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 85: 605-608, 1990.
11. Takematsu H, Tagami H: Mode of release of interleukin-8 from proliferating human epidermal keratinocytes in vitro. Exp Dermatol 2: 121-124, 1993.
12. 3 analogue MC903 on secretion of interleukin-1 alpha (IL-1α) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1). J Dermatol Sci 7: 24-31, 1994.
13. Schulz BS, Michel G, Wagner S, Suss R, Beetz A, Peter RU, Kemeny L, Ruzicka T: Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol 151: 4399-4406, 1993.
14. 3 on normal and psoriatic keratinocytes. Br J Dermatol 123: 93-98, 1990.
15. 3. Endocrinology 113: 1950-1957, 1983.
16. 3 to induce keratinocyte differentiation. J Dermatol 17: 707-709, 1990.
17. 3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166: 916-923, 1990.
18. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free condition. J Invest Dermatol 86: 706-714, 1986.
19. 3 analogue (MC 903) in a double-blind study. Br J Dermatol 119: 223-230, 1988.
20. 3 on adenylate cyclase and protein kinase C in pig epidermis. Acta Derm Venereol (Stockh) 71: 6-10, 1991.
21. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176: 1020-1025, 1991.
22. 3 modulates Ia antigen expression induced by interferon-γ and prostaglandin E2 production in Pam 212 cells. Br J Dermatol 126: 266-274, 1992.
23. 3 modulation of HLA-DR mRNA induced by gamma-interferon in cultured epithelial tumor cell lines. J Dermatol 20: 581-584, 1993.
24. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol 104: 113-117, 1995.
25. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487-493, 1993.
26. 3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. J Invest Dermatol 103: 323-329, 1994.
27. 3 with an oxygen atom in the side chain skeleton. FEBS Lett 226: 58-62, 1987.
28. Boyce ST, Ham RG: Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81: 33S-40S, 1983.
29. + + increase in human epidermal keratinocytes. J Invest Dermatol 96: 234-237, 1991.
30. Buttke TM, McCubrey JA, Owen TC: Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods 157: 233-240, 1993.
31. Kaplan A, Matsue H, Shibaki A, Kawashima T, Kobayashi H, Ohkawara A: The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. J Dermatol Sci 10: 130-138, 1995.
32. 3. J Nutr Sci Vitaminol 35: 529-553, 1989.
33. Pols HAP, Birkenhäger JC, van Leeuwen JPTM: Vitamin D analogues: from molecule to clinical application. Clin Endocrinol 40: 285-291, 1994.
34. Bikle DD, Abe-Hashimoto J, Su MJ, Felt S, Gibson DFC, Pillai S: 22-Oxacalcitriol is a less potent regulator of keratinocyte proliferation and differentiation due to decreased cellular uptake and enhanced catabolism. J Invest Dermatol 105: 693-698, 1995.
35. 3 analogue, 1α,24-dihydroxycholecalciferol. Br J Dermatol 115: 431-433, 1995.
36. 3. Arch Dermatol 25: 231-234, 1989.